I admit that number shocked me as well. KB doesn't usually make things up though from what I remember. I have been a fan of Prurisol from the beginning. It is not reflected in the price at all in my opinion. It has blockbuster potential. It was better than Methotrexate in a side by side comparison using the same mouse model so I think the odds are in our favor. 50 to 100 million out of that drug somehow and I think the market caps shoots past one billion instantly. Uplisting would follow and then who knows. To the moon maybe!
![](/images/icons/icon_smile.gif)